LEDDA, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 259
EU - Europa 119
AS - Asia 115
Totale 493
Nazione #
US - Stati Uniti d'America 257
SG - Singapore 78
IT - Italia 48
IE - Irlanda 30
CN - Cina 16
SE - Svezia 15
GB - Regno Unito 8
DE - Germania 6
ID - Indonesia 5
FI - Finlandia 4
HK - Hong Kong 4
VN - Vietnam 4
KR - Corea 3
BE - Belgio 2
IN - India 2
AT - Austria 1
BN - Brunei Darussalam 1
CA - Canada 1
DK - Danimarca 1
FR - Francia 1
HN - Honduras 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 493
Città #
Singapore 72
Chandler 52
Santa Clara 33
Dublin 30
Turin 17
Columbus 16
Nyköping 14
Genoa 8
Medford 8
Ashburn 6
Milan 6
Jakarta 5
Princeton 5
Torino 5
Hangzhou 4
West Jordan 4
Wilmington 4
Beijing 3
Hebei 3
Helsinki 3
Munich 3
Chengdu 2
Cuneo 2
Delhi 2
Fairfield 2
Hong Kong 2
London 2
New York 2
Norwalk 2
Seoul 2
Upper Marlboro 2
Amsterdam 1
Bandar Seri Begawan 1
Brabrand 1
Brussels 1
Chicago 1
Cologne 1
Dallas 1
Gaimersheim 1
Guangzhou 1
Hefei 1
Houston 1
Jacksonville 1
Kiel 1
Lappeenranta 1
Liverpool 1
Los Angeles 1
Malmö 1
Manila 1
Ormond Beach 1
San Diego 1
Schoten 1
Seodaemun-gu 1
Shanghai 1
Shenyang 1
Southwark 1
Taipei City 1
Tegucigalpa 1
Tolentino 1
Victoria 1
Vienna 1
Warsaw 1
Totale 352
Nome #
COVID-19 and Parkinson's Disease: What We Know So Far? 67
Time to onset and duration of botulinum toxin efficacy in movement disorders 63
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 59
Neurological comorbidities and COVID-19-related case fatality: A cohort study 45
G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome 45
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 29
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 26
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 26
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 24
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 22
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel 20
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 19
CACNA1A variant associated with generalized dystonia 11
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 11
Longitudinal Assessment of Botulinum Toxin Treatment for Lateral Trunk Flexion and Pisa Syndrome in Parkinson's Disease: Real-life, Long-Term Study 10
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 9
Neurological symptoms in adults with Gaucher disease: a systematic review 9
Effects of Continuous Dopaminergic Stimulation on Parkinson's Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion 9
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 8
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 5
Totale 517
Categoria #
all - tutte 3.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 1 2 3 11
2021/202266 1 3 3 3 3 2 1 2 6 1 24 17
2022/2023152 14 19 3 15 11 36 10 7 10 10 9 8
2023/2024100 9 14 2 2 7 20 1 1 1 17 5 21
2024/2025182 12 39 11 49 71 0 0 0 0 0 0 0
Totale 517